Tianxiang Chen

2.6k citations
40 papers · 1.7k indexed · h-index 24
Topics
Cancer-related molecular mechanisms research (18 papers)RNA modifications and cancer (12 papers)MicroRNA in disease regulation (10 papers)
Journals
SHILAP Revista de lepidopterologíaPLoS ONEThe Science of The Total Environment

In The Last Decade

Tianxiang Chen

39 papers receiving 1.7k citations

Peers

Tianxiang Chen
Comparison fields: 5 of 95
  • Molecular Biology 1.2k
  • Cancer Research 1.1k
  • Oncology 200
  • Immunology 162
  • Epidemiology 161
Replace Yan–Ling Meng with:
Yan–Ling Meng China
Xiuying Cui China
Pilar Gonzalo Spain
Jill Magnus United States
Zhendong Yu China
Wenjuan Pu China
María José Ruiz‐Hidalgo Spain
Jian Han China
Tianxiang Chen relative to Yan–Ling Meng China Yan–Ling Meng's profile →
Citations per field
00.5×3.5×
Yan–Ling Meng · 1×
Citations per year

Countries citing papers authored by Tianxiang Chen

Since Specialization
Citations

This map shows the geographic impact of Tianxiang Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianxiang Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianxiang Chen more than expected).

Fields of papers citing papers by Tianxiang Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tianxiang Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianxiang Chen. The network helps show where Tianxiang Chen may publish in the future.

Co-authorship network of co-authors of Tianxiang Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Tianxiang Chen. A scholar is included among the top collaborators of Tianxiang Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianxiang Chen. Tianxiang Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 7
3 18
4 49
5 46
6 58
7 24
8 72
9 35
10 5
11 23
12 31
13 21
14 51
15 309
16 103
17 44
18 108
19 30
20 105

About Tianxiang Chen

Tianxiang Chen is a scholar working on Cancer Research, Molecular Biology and Hepatology, having authored 40 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (18 papers), RNA modifications and cancer (12 papers) and MicroRNA in disease regulation (10 papers). The work is most often cited by research in Cancer Research (1.1k citations), Molecular Biology (1.2k citations) and Hepatology (87 citations). Tianxiang Chen has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Kangsheng Tu, Yufeng Wang, Bowen Yao, Liankang Sun, Runkun Liu, Qingguang Liu, Yongshen Niu, Wei Yang, Liang Wang and Zhikui Liu. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Science of The Total Environment.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026